Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63.
World Health Organization. Cancer 2024. Breast cancer (who.int) (accessed November 26, 2024).
Yusuf I, Atanda AA, Ali BU, Yusuf I, Atanda AA, Ali BU, Imam MI, Mohammed AZ, Ochicha O, Muhammad SH. Cancer in Kano northwestern Nigeria: a 10-year update of Kano cancer registery. Ann Trop Pathol. 2017;8(2):87–9.
Argolo DF, Hudis CA, Iyengar NM. The impact of obesity on breast cancer. Curr Oncol Rep. 2018;20:47.
Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S. The weight of obesity in breast cancer progression and metastasis: clinical and molecular perspectives. Semin Cancer Biol. 2020;60:274–84.
Rose DP, Vona-Davis L. Interaction between menopausal status and obesity in affecting breast cancer risk. Maturitas. 2010;66:33–8.
Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123:627–35.
Wang X, Li L, Gao J, Liu J, Guo M, Liu L, et al. The association between body size and breast cancer in Han women in Northern and Eastern China. Oncologist. 2016;21:1362–8.
PubMed PubMed Central Google Scholar
Feola A, Ricci S, Kouidhi S, Rizzo A, Penon A, Formisano P, et al. Multifaceted breast cancer: the molecular connection with obesity: breast cancer: the molecular connection with obesity. J Cell Physiol. 2017;232:69–77.
Hursting SD, DiGiovanni J, Dannenberg AJ, Azrad M, LeRoith D, Demark-Wahnefried W, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res. 2012;5:1260–72.
Barb D, Williams CJ, Neuwirth AK, Mantzoros CS. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr. 2007;86:858S-866S.
Paz-Filho G. Associations between adipokines and obesity-related cancer. Front Biosci. 2011;16:1634.
Kaklamani VG. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008;300:1523.
CAS PubMed PubMed Central Google Scholar
Virginia DM, Patramurti C, Fenty -, Setiawan CH, Julianus J, Hendra P, et al. Single Nucleotide Polymorphism in the 3’ Untranslated Region of PRKAA2 on Cardiometabolic Parameters in Type 2 Diabetes Mellitus Patients Who Received Metformin. Ther Clin Risk Manag 2022; 18:349–57.
Mahbouli S, Der Vartanian A, Ortega S, Rougé S, Vasson M-P, Rossary A. Leptin induces ROS via NOX5 in healthy and neoplastic mammary epithelial cells. Oncol Rep. 2017;38:3254–64.
Govindarajan S, Saxena A, Mahajan B, Mahto M. Association of serum adiponectin levels and ADIPOQ SNP rs2241766 with breast cancer risk in Indian women. J Cancer Res Ther. 2023;19:1379–84.
Naimo GD, Paolì A, Giordano F, Forestiero M, Panno ML, Andò S, et al. Unraveling the role of adiponectin receptors in obesity-related breast cancer. Int J Mol Sci. 2023;24:8907.
CAS PubMed PubMed Central Google Scholar
Forssati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077–80.
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470–5.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
Sengar P, Juárez P, Verdugo-Meza A, Arellano DL, Jain A, Chauhan K, et al. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. J Nanobiotechnology. 2018;16:19.
PubMed PubMed Central Google Scholar
Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012;33:547–94.
CAS PubMed PubMed Central Google Scholar
Gross AL, Newschaffer CJ, Hoffman-Bolton J, Rifai N, Visvanathan K. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev. 2013;22:1319–24.
CAS PubMed PubMed Central Google Scholar
Jardé T, Caldefie-Chézet F, Goncalves-Mendes N, Mishellany F, Buechler C, Penault-Llorca F, et al. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer. 2009;16:1197–210.
Gu L, Cao C, Fu J, Li Q, Li D-H, Chen M-Y. Serum adiponectin in breast cancer: a meta-analysis. Medicine (Baltimore). 2018;97: e11433.
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439–51.
Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer. 2008;98:370–9.
CAS PubMed PubMed Central Google Scholar
Al Awadhi SA, Al Khaldi RM, Al Rammah T, Kapila K, Mojiminiyi OA. Associations of adipokines & insulin resistance with sex steroids in patients with breast cancer. Indian J Med Res. 2012;135:500–5.
CAS PubMed PubMed Central Google Scholar
Chen D-C, Chung Y-F, Yeh Y-T, Chaung H-C, Kuo F-C, Fu O-Y, et al. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett. 2006;237:109–14.
Assiri AMA, Kamel HFM, Hassanien MFR. Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers. Dis Markers. 2015;2015:1–9.
Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L. The association between leptin level and breast cancer: a meta-analysis. PLoS ONE. 2013;8: e67349.
CAS PubMed PubMed Central Google Scholar
Parida S, Siddharth S, Sharma D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci. 2019;20: 2519.
CAS PubMed PubMed Central Google Scholar
Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH, et al. Total Cholesterol and Cancer Risk in a Large Prospective Study in Korea. J Clin Oncol 2011;29:1592–8.
Fiorenza AM, Branchi A, Sommariva D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int J Clin Lab Res. 2000;30:141–5.
Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science. 2013;342:1094–8.
CAS PubMed PubMed Central Google Scholar
Al Khaldi RM, Al Mulla F, Al Awadhi S, Kapila K, Mojiminiyi OA. Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. Dis Markers. 2011;30:197–212.
CAS PubMed PubMed Central Google Scholar
Guo M, Duan X, Cui S, Tian F, Cao X, Geng C, et al. Circulating high-molecular-weight (HMW) adiponectin level is related with breast cancer risk better than total adiponectin: a case-control study. PLoS ONE. 2015;10: e0129246.
PubMed PubMed Central Google Scholar
Sexton KR, Franzini L, Day RS, Brewster A, Vernon SW, Bondy ML. A review of body size and breast cancer risk in Hispanic and African American women. Cancer. 2011;117:5271–81.
Erbay B, Yilmaz TU, Eraldemir C, Uren N, Tiryaki C, Ergul E, et al. The relationship between adiponectin and breast cancer. J Breast Health. 2016;12:67–71.
PubMed PubMed Central Google Scholar
Loos RJ, Ruchat S, Rankinen T, Tremblay A, Pérusse L, Bouchard C. Adiponectin and adiponectin receptor gene variants in relation to resting metabolic rate, respiratory quotient, and adiposity-related phenotypes in the Québec family study. Am J Clin Nutr. 2007;85:26–34.
Cerda-Flores RM, Camarillo-Cárdenas KP, Gutiérrez-Orozco G, Villarreal-Vela MP, Garza-Guajardo R, Ponce-Camacho MA, et al. ADIPOQ single nucleotide polymorphisms and breast cancer in northeastern Mexican women. BMC Med Genet. 2020;21(1): 187.
Comments (0)